Program Intensive Habilitation (PIH) for Young Children With Early Brain Damage
Key facts
- Who runs it
- Sorlandet Hospital HF
- Where
- Norway1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 93 people enrolled
- Started
- 10 Oct 2021
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Program Intensified Habilitation
- Habilitation as usual
- Record updated
- 7 May 2026
Who can take part
- Age
- 2 years to 7 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- age 2 - 6 years at the start of the program
- a diagnosis of severe cerebral palsy or similar motor disability of non-progressive etiology (GMFCS level IV-V),
- being able to participate in group sessions
- having parents who want to take an active part in their child's training
- least one of the parents must speak fluent Norwegian or English
Who cannot take part
- children with progressive disorders
- co-morbidity like autism spectrum disorder, severe visual and hearing impairments or intractable epilepsy that worsen with physical activity
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
By longitudinal, prospective research in children with neurodisabilities including severe motor impairments and their parents to explore the beneficial effects of participating in an intensive habilitation program on the child's adaptive functioning and parental empowerment in order to treat and reduce the consequences of early brain damage.
The 2 groups in the trial
- Intervention groupTreatment being tested
Half of the study participants will be randomized to the intensive habilitation program the first year of program. The second year of program this group of participants will be offered habilitation "as usual".
Treatment: Program Intensified Habilitation and Habilitation as usual
- Control groupOther group
Half of the study participants will be randomized to "treatment as usual" the first year of program, then offered the intensive program during the second year ("stepped wedge design").
Treatment: Program Intensified Habilitation and Habilitation as usual
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of a Norwegian Model of an Intensive Habilitation Program for Young Children With Early Brain Damage - a Multicentre Randomized Controlled Trial.
- Record updated
- 7 May 2026